The Claim
The prevalence and usage trends of melatonin supplements among the US adult population were systematically tracked from 1999 to 2018, providing a descriptive overview of temporal shifts in consumption patterns based on aggregate survey data.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
This claim simply tracks how often US adults have been taking melatonin supplements over the last twenty years. It looks at survey data to see how popular these supplements have become over time, without checking if they actually help or harm anyone's health.
See the scientific wording
Reported prevalence and usage trends of melatonin supplements among US adults were systematically examined over a twenty-year period spanning from 1999 through 2018, providing a descriptive overview of consumption patterns without assessing health outcomes or biological mechanisms. This longitudinal tracking focuses exclusively on aggregate survey responses to capture temporal shifts in supplement adoption across the general adult population.
What the research says
1 studyStudy: Trends in Use of Melatonin Supplements Among US Adults, 1999-2018.
The abstract explicitly states that the research focuses on tracking reported prevalence and temporal trends in supplement usage. By relying on aggregate survey data over a two-decade span, the study establishes a descriptive baseline of consumption habits without attempting to measure physiological effects or causal health impacts. This approach ensures that findings remain strictly observational and focused on public health monitoring rather than therapeutic evaluation.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.